Heritage Trust Co purchased a new stake in Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) in the 4th quarter, according to its most recent filing with the SEC. The fund purchased 16,349 shares of the financial services provider’s stock, valued at approximately $3,033,000.
Several other institutional investors also recently bought and sold shares of MRSH. AXQ Capital LP acquired a new stake in shares of Marsh & McLennan Companies during the 4th quarter worth $2,554,000. Fielder Capital Group LLC acquired a new stake in shares of Marsh & McLennan Companies during the 4th quarter worth $385,000. Vantus Wealth LLC acquired a new stake in shares of Marsh & McLennan Companies during the 4th quarter worth $208,000. KERR FINANCIAL PLANNING Corp acquired a new stake in shares of Marsh & McLennan Companies during the 4th quarter worth $27,000. Finally, Mawer Investment Management Ltd. acquired a new stake in shares of Marsh & McLennan Companies during the 4th quarter worth $724,583,000. 87.99% of the stock is currently owned by institutional investors and hedge funds.
Marsh & McLennan Companies Stock Down 0.1%
Shares of NYSE MRSH opened at $162.44 on Tuesday. The company has a debt-to-equity ratio of 1.28, a quick ratio of 1.11 and a current ratio of 1.11. The stock’s 50-day simple moving average is $164.41 and its 200-day simple moving average is $171.56. Marsh & McLennan Companies, Inc. has a 1 year low of $157.74 and a 1 year high of $235.78. The firm has a market cap of $78.47 billion, a price-to-earnings ratio of 20.30, a PEG ratio of 2.33 and a beta of 0.62.
Analyst Ratings Changes
A number of research firms have recently commented on MRSH. Citigroup upgraded Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 price objective for the company in a report on Wednesday, May 6th. Weiss Ratings downgraded Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 11th. JPMorgan Chase & Co. dropped their price objective on Marsh & McLennan Companies from $226.00 to $206.00 and set an “overweight” rating for the company in a report on Thursday, April 9th. Piper Sandler decreased their price target on shares of Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating for the company in a research report on Tuesday, May 26th. Finally, Raymond James Financial upgraded Marsh & McLennan Companies from an “outperform” rating to a “strong-buy” rating and set a $225.00 price target for the company in a report on Tuesday, February 17th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, ten have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Marsh & McLennan Companies presently has an average rating of “Hold” and a consensus target price of $203.56.
Read Our Latest Research Report on MRSH
Insider Transactions at Marsh & McLennan Companies
In related news, CEO John Q. Doyle sold 16,655 shares of the company’s stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $183.30, for a total value of $3,052,861.50. Following the completion of the sale, the chief executive officer directly owned 116,811 shares in the company, valued at approximately $21,411,456.30. This represents a 12.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Corporate insiders own 0.38% of the company’s stock.
Marsh & McLennan Companies Profile
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Featured Stories
- Five stocks we like better than Marsh & McLennan Companies
- Why 1 Little-Known ETF Is Riding the AI Chip Shortage
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
